Nomura Holdings
IRD

Nomura Holdings’s Opus Genetics IRD Stock Holding History

Nomura Holdings’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-119
Closed -$30K – 2135
2015
Q3 		$30K Buy
+119
New +$32.3K ﹤0.01% 1572
2014
Q1 		– Sell
-229
Closed -$55K – 2946
2013
Q4 		$55K Sell
229
-57
-20% -$12K ﹤0.01% 1883
2013
Q3 		$62K Buy
286
+56
+24% +$13.1K ﹤0.01% 2114
2013
Q2 		$49K Buy
+230
New +$39.5K ﹤0.01% 2075

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BMC
Benin Management Corp Wilton, Connecticut $494M AUM 25.95% 1-Year Est. Return

Nomura Holdings's IRD Position: Q4 2015 in Review

Nomura Holdings sold out of Opus Genetics (IRD) in Q4 2015, closing a stake of 119 shares — an estimated $30K sold.

Nomura Holdings first reported a position in IRD in Q2 2013 and held it in 4 quarters. The position peaked at $62K in Q3 2013. 34 funds tracked by Wall St. Rank hold IRD as of Q4 2015.

  • Nomura Holdings reported no remaining Opus Genetics position as of Q4 2015 after selling out during the quarter.
  • Nomura Holdings sold 119 Opus Genetics shares in Q4 2015, an estimated $30K.
  • Nomura Holdings first reported a position in Opus Genetics in Q2 2013 and held it in 4 quarters.
  • Nomura Holdings's Opus Genetics position peaked at $62K in Q3 2013.
  • 34 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2015.

Based on Nomura Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.